Table 2.
SB | BL-ALI | Treatment | Lung injury | Time | Injury type | Mode | Inter-action | ||
PaO2/FiO2, mm Hg | HCl | + | 132 ± 18 | 150 ± 50 | a | TMa | |||
- | 151 ± 58 | 137 ± 104 | |||||||
OA | + | 145 ± 51 | 184 ± 116 | ||||||
- | 146 ± 68 | 109 ± 46 | |||||||
HR, beats per minute | HCl | + | 96 ± 12 | 112 ± 11 | a | a | |||
- | 100 ± 22 | 108 ± 20 | |||||||
OA | + | 102 ± 11 | 110 ± 23 | ||||||
- | 112 ± 18 | 119 ± 23 | |||||||
MAP, mm Hg | HCl | + | 79 ± 8 | 86 ± 9b | a | a | |||
- | 77 ± 23 | 92 ± 13b | |||||||
OA | + | 93 ± 12d | 97 ± 13b, d | ||||||
- | 101 ± 10d | 104 ± 15b, d | |||||||
CVP, mm Hg | HCl | + | 11 ± 2 | 10 ± 2b | a | ||||
- | 12 ± 3 | 12 ± 2b | |||||||
OA | + | 15 ± 2d | 14 ± 2b, d | ||||||
- | 15 ± 4d | 14 ± 3b, d | |||||||
SVR, dyne-second/cm5 | HCl | + | 1,335 ± 198 | 1,057 ± 191b | a | a | a | ||
- | 1,255 ± 429 | 1,072 ± 333b | |||||||
OA | + | 1,513 ± 344 | 1,281 ± 388b | ||||||
- | 1,490 ± 384 | 1,060 ± 206b | |||||||
CO, L/minute | HCl | + | 4.1 ± 0.3 | 4.6 ± 0.8 | a | a | |||
- | 4.2 ± 0.9c | 4.8 ± 0.9c | |||||||
OA | + | 4.2 ± 0.7 | 4.3 ± 0.8 | ||||||
- | 4.8 ± 0.8c | 5.5 ± 0.7c | |||||||
DO2, mL/minute | HCl | + | 323 ± 28 | 393 ± 71 | a | a | |||
- | 336 ± 63 | 369 ± 89 | |||||||
OA | + | 335 ± 89 | 360 ± 48 | ||||||
- | 408 ± 80 | 430 ± 118 | |||||||
VO2, mL/minute | HCl | + | 181 ± 31 | 172 ± 33 | a | a | |||
- | 169 ± 23 | 172 ± 32 | |||||||
OA | + | 159 ± 27c | 147 ± 34c | ||||||
- | 154 ± 32c | 167 ± 42c | |||||||
Shunt < 0.005, %QT | HCl | + | 27.1 ± 6.2 | 23.3 ± 12.7 | a | TMa | |||
- | 27.7 ± 7.9 | 37.4 ± 17.4b | |||||||
OA | + | 32.6 ± 18.9 | 26.0 ± 17.9 | ||||||
- | 32.4 ± 12.4 | 47.2 ± 17.1b | |||||||
Dead space > 100, %Ve | HCl | + | 33.0 ± 5.5 | 45.1 ± 11.8 | a | ||||
- | 34.4 ± 5.9 | 38.7 ± 3.9 | |||||||
OA | + | 39.1 ± 6.6 | 44.9 ± 12.8 | ||||||
- | 39.0 ± 6.0 | 46.2 ± 12.2 |
Pre-acute lung injury (ALI) (Table S1 in additional data file) was tested only against baseline ALI (BL-ALI). Post hoc testing was always performed if a significant F ratio for a factor or the interaction of factors was obtained by repeated measures analysis of variance (aP < 0.05), but only significant differences are marked: bP < 0.05 for within-group differences (BL-ALI versus Treatment), cP < 0.05 for between-group differences (HCl-ALI versus OA-ALI), and dP < 0.05 for between-group differences (PCV + SB versus PCV – SB) (post hoc Tukey multiple comparison test). +, pressure-controlled ventilation with maintained spontaneous breathing; -, pressure-controlled ventilation without spontaneous breathing; CO, cardiac output; CVP, central venous pressure; DO2, oxygen delivery; HCl, hydrochloric acid-induced acute lung injury; HCl-ALI, hydrochloric acid-induced acute lung injury; HR, heart rate; M, mode; MAP, mean arterial pressure; OA, oleic acid-induced acute lung injury; OA-ALI, oleic acid-induced acute lung injury; PaO2/FiO2, arterial partial pressure of oxygen/inspiratory fraction of oxygen; PCV + SB, pressure-controlled ventilation with spontaneous breathing; PCV – SB, pressure-controlled ventilation without spontaneous breathing; %QT, percentage of cardiac output; SB, spontaneous breathing; SVR, systemic vascular resistance; T, time; , ventilation/perfusion (ratio); %Ve, percentage of minute ventilation; VO2, oxygen consumption.